Menarini lands in America acquiring the biopharmaceutical company Stemline Therapeutics Inc.
Menarini acquires the U.S. biopharmaceutical company Stemline Therapeutics, focused on the development and commercialization of novel oncology therapeutics. The transaction for this Company – previously listed on Nasdaq – was already announced in early May 2020 and then completed in early June for an aggregate cash consideration up to $ 677 million. Menarini in America […]
Read more